Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Analogues of IP3

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Saleem, Huma ^a   Tovey, Stephen C ^a   Rahman, Taufiq ^a   Riley, Andrew M ^b   Potter, Barry V L ^b   Taylor, Colin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MALACHITE GREEN; PHOSPHATE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHROMATOPHORE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL LINE; GENE EXPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; KINETICS; LIGANDS; MICE; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN BINDING; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; MAMMALIA; VERTEBRATA;

EID: 84872839305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054877     Document Type: Article

References (57)

1. Taylor CW, Tovey SC, (2010) IP3 receptors: toward understanding their activation. Cold Spring Harb Persp Biol 2: a004010.
2. Ludtke SJ, Tran TP, Ngo QT, Moiseenkova-Bell VY, Chiu W, et al. (2011) Flexible architecture of IP3R1 by cryo-EM. Structure 19: 1192-1199.
3. Bosanac I, Alattia J-R, Mal TK, Chan J, Talarico S, et al. (2002) Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand. Nature 420: 696-700.
4. Rossi AM, Riley AM, Tovey SC, Rahman T, Dellis O, et al. (2009) Synthetic partial agonists reveal key steps in IP3 receptor activation. Nat Chem Biol 5: 631-639.
5. Chan J, Yamazaki H, Ishiyama N, Seo MD, Mal TK, et al. (2010) Structural studies of inositol 1,4,5-trisphosphate receptor: coupling ligand binding to channel gating. J Biol Chem 285: 36092-36099.
6. Yamazaki H, Chan J, Ikura M, Michikawa T, Mikoshiba K, (2010) Tyr-167/Trp-168 in type1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening. J Biol Chem 285: 36081-36091.
7. Seo M-D, Velamakanni S, Ishiyama N, Stathopulos PB, Rossi AM, et al. (2012) Structural and functional conservation of key domains in InsP3 and ryanodine receptors. Nature 483: 108-112.
8. Ramos-Franco J, Galvan D, Mignery GA, Fill M, (1999) Location of the permeation pathway in the recombinant type-1 inositol 1,4,5-trisphosphate receptor. J Gen Physiol 114: 243-250.
9. Uchida K, Miyauchi H, Furuichi T, Michikawa T, Mikoshiba K, (2003) Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 278: 16551-16560.
10. Foskett JK, White C, Cheung KH, Mak DO, (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87: 593-658.
11. Marchant JS, Taylor CW, (1997) Cooperative activation of IP3 receptors by sequential binding of IP3 and Ca2+ safeguards against spontaneous activity. Curr Biol 7: 510-518.
12. Fujino I, Yamada N, Miyawaki A, Hasegawa M, Furuichi T, et al. (1995) Differential expression of type 2 and type 3 inositol 1,4,5-trisphosphate receptor mRNAs in various mouse tissues: in situ hybridization study. Cell Tissue Res 280: 201-210.
13. Yamamoto-Hino M, Miyawaki A, Kawano H, Sugiyama T, Furuichi T, et al. (1995) Immunohistochemical study of inositol 1,4,5-trisphosphate receptor type 3 in rat central nervous system. Neuroreport 6: 273-276.
14. Taylor CW, Genazzani AA, Morris SA, (1999) Expression of inositol trisphosphate receptors. Cell Calcium 26: 237-251.
15. Vermassen E, Parys JB, Mauger J-P, (2004) Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96: 3-17.
16. Iwai M, Michikawa T, Bosanac I, Ikura M, Mikoshiba K, (2007) Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J Biol Chem 282: 12755-12764.
17. Patterson RL, Boehning D, Snyder SH, (2004) Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 73: 437-465.
18. Ando H, Mizutani A, Matsu-ura T, Mikoshiba K, (2003) IRBIT, a novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor. J Biol Chem 278: 10602-10612.
19. Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, et al. (2005) Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120: 85-98.
20. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, et al. (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309: 2232-2234.
21. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, et al. (1996) Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379: 168-171.
22. Potter BVL, Lampe D, (1995) Chemistry of inositol lipid mediated cellular signaling. Angew Chem Int Ed Eng 34: 1933-1972.
23. Sureshan KM, Riley AM, Rossi AM, Tovey SC, Dedos SG, et al. (2009) Activation of IP3 receptors by synthetic bisphosphate ligands. Chem Comm: 1204-1206.
24. Mills SJ, Potter BVL, (1996) Synthesis of d- and l-myo-inositol 1,4,6-trisphosphate, regioisomers of a ubiquitous second messenger. J Org Chem 61: 8980-8987.
25. Inoue T, Kikuchi K, Hirose K, Iino M, Nagano T, (1999) Synthesis and evaluation of 1-position-modified inositol 1,4,5-trisphosphate analogs. Bioorg Med Chem Lett 9: 1967-1702.
26. Sureshan KM, Riley AM, Thomas MP, Tovey SC, Taylor CW, et al. (2012) Contribution of phosphates and adenine to the potency of adenophostins at the IP3 receptor: synthesis of all possible bisphosphates of adenophostin A. J Med Chem. 55: 1706-1720.
27. Poinas A, Backers K, Riley AM, Mills SJ, Moreau C, et al. (2005) Study of the interaction of the catalytic domain of Ins(1,4,5)P3 3-kinase A with inositol phosphate analogues. ChemBioChem 6: 1449-1457.
28. Riley AM, Mahon MF, Potter BVL, (1997) Rapid synthesis of the enantiomers of myo-inositol-1,3,4,5-tetrakisphosphate by direct chiral desymmetrization of myo-inositol orthoformate. Angew Chem Int Ed Eng 36: 1472-1474.
29. Cardy TJA, Traynor D, Taylor CW, (1997) Differential regulation of types 1 and 3 inositol trisphosphate receptors by cytosolic Ca2+. Biochem J 328: 785-793.
30. Rossi A, Sureshan KM, Riley AM, Potter BVL, Taylor CW, (2010) Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors. Br J Pharmacol 161: 1070-1085.
31. Tovey SC, Dedos SG, Rahman T, Taylor EJA, Pantazaka E, et al. (2010) Regulation of inositol 1,4,5-trisphosphate receptors by cAMP independent of cAMP-dependent protein kinase. J Biol Chem 285: 12979-12989.
32. Sugawara H, Kurosaki M, Takata M, Kurosaki T, (1997) Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 16: 3078-3088.
33. Pantazaka E, Taylor CW, (2011) Differential distribution, clustering and lateral diffusion of subtypes of inositol 1,4,5-trisphosphate receptor. J Biol Chem 286: 23378-23387.
34. Rahman TU, Skupin A, Falcke M, Taylor CW, (2009) Clustering of IP3 receptors by IP3 retunes their regulation by IP3 and Ca2+. Nature 458: 655-659.
35. Tovey SC, Sun Y, Taylor CW, (2006) Rapid functional assays of intracellular Ca2+ channels. Nature Prot 1: 259-263.
36. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2006) Comparative protein structure modeling using Modeller. Curr Prot Bioinform 15: 5.6.1-5.6.30.
37. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375-W383.
38. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
39. Trott O, Olson AJ, (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461.
40. Merlino A, Benitez D, Campillo NE, Paez JA, Tinoco LW, et al. (2012) Amidines bearing benzofuroxan or benzimidazole 1,3-dioxide core scaffolds as Trypanosoma cruzi-inhibitors: structural basis for their interactions with cruzipain. Med Chem Comm 3: 90-101.
41. Irvine RF, Schell MJ, (2001) Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2: 327-338.
42. Loomis-Husselbee JW, Walker CD, Bottomley JR, Cullen PJ, Irvine RF, et al. (1998) Modulation of Ins(2,4,5)P3-stimulated Ca2+ mobilization by Ins(1,3,4,5)P4: enhancement by activated G-proteins, and evidence for the involvement of a GAP1 protein, a putative Ins(1,3,4,5)P4 receptor. Biochem J 331: 947-952.
43. Bird GSJ, Putney JW Jr, (1996) Effect of inositol 1,3,4,5-trisphosphate on inositol trisphosphate-activated Ca2+ signaling in mouse lacrimal cells. J Biol Chem 271: 6766-6770.
44. Burgess GM, McKinney JS, Irvine RF, Putney JW, (1985) Inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate formation in Ca2+-mobilizing-hormone-activated cells. Biochem J 232: 237-243.
45. Wilcox RA, Primrose WU, Nahorski SR, Challiss RAJ, (1998) New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharmacol Sci 19: 467-475.
46. Nerou EP, Riley AM, Potter BVL, Taylor CW, (2001) Selective recognition of inositol phosphates by subtypes of inositol trisphosphate receptor. Biochem J 355: 59-69.
47. Kozikowski AP, Ognyanov VI, Fauq AH, Nahorski SR, Wilcox RA, (1993) Synthesis of 1d-3-deoxy-, 1d-2,3-dideoxy, and 1d-2,3,6-trideoxy-myo-inositol 1,4,5-trisphosphate from quebrachitol, their binding affinities, and calcium release activity. J Am Chem Soc 115: 4429-4434.
48. Inoue T, Kikuchi K, Hirose K, Iino M, Nagano T, (2001) Small molecule-based laser inactivation of inositol 1,4,5-trisphosphate receptor. Chem Biol 8: 9-15.
49. Hagiwara T, Motomizu S, (1994) Equilibrium and kinetic studies on the formation of the triphenylmethanols from triphenylmethane dyes. Bull Chem Soc Jpn 67: 390-397.
50. Bosanac I, Yamazaki H, Matsu-ura T, Michikawa M, Mikoshiba K, et al. (2005) Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor. Mol Cell 17: 193-203.
51. Lin CC, Baek K, Lu Z, (2011) Apo and InsP3-bound crystal structures of the ligand-binding domain of an InsP3 receptor. Nat Struct Mol Biol 18: 1172-1174.
52. DeLisle S, Radenberg T, Wintermantel MR, Tietz C, Parys JB, et al. (1994) Second messenger specificity of the inositol trisphosphate receptor: reappraisal based on novel inositol phosphates. Am J Physiol 266: C429-C436.
53. Lu P-J, Gou D-M, Shieh W-R, Chen C-S, (1994) Molecular interactions of endogenous d-myo-inositol phosphates with the intracellular d-myo-inositol 1,4,5-trisphosphate recognition site. Biochemistry 33: 11586-11597.
54. Nakanishi W, Kikuchi K, Inoue T, Hirose K, Iino M, et al. (2002) Hydrophobic modifications at 1-phosphate of inositol 1,4,5-trisphosphate analogues enhance receptor binding. Bioorg Med Chem Lett 12: 911-913.
55. Wilcox RA, Fauq A, Kozikowski AP, Nahorski SR, (1997) Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor. FEBS Lett 402: 241-245.
56. Marchant JS, Chang Y-T, Chung S-K, Irvine RF, Taylor CW, (1997) Rapid kinetic measurements of 45Ca2+ mobilization reveal that Ins(2,4,5)P3 is a partial agonist of hepatic InsP3 receptors. Biochem J 321: 573-576.
57. Lampe D, Mills SJ, Potter BVL (1992) Total synthesis of the second messenger analogue d-myo-inositol 1-phosphorothioate,4,5-bisphosphate: optical resolution of dl-1-O-allyl-2,3,6-tri-O-benzyl-myo-inositol and fluorescent labelling of myo-inositol 1,4,5-trisphosphate. J Chem Soc Perkin Trans: 2899-2906.